Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 37

1.

Survival was Significantly Better with Surgical/Medical/Radiation Co-interventions in a Single-Institution Practice Audit of Frameless Stereotactic Radiosurgery.

Taggar A, MacKenzie J, Li H, Lau H, Lim G, Nordal R, Hudson A, Khan R, Spencer D, Voroney JP.

Cureus. 2016 May 17;8(5):e612. doi: 10.7759/cureus.612.

2.

Breast cancer brain metastases: the last frontier.

Leone JP, Leone BA.

Exp Hematol Oncol. 2015 Nov 24;4:33. doi: 10.1186/s40164-015-0028-8. eCollection 2015. Review.

3.

Neurocognitive functioning and health-related quality of life in patients treated with stereotactic radiotherapy for brain metastases: a prospective study.

Habets EJ, Dirven L, Wiggenraad RG, Verbeek-de Kanter A, Lycklama À Nijeholt GJ, Zwinkels H, Klein M, Taphoorn MJ.

Neuro Oncol. 2016 Mar;18(3):435-44. doi: 10.1093/neuonc/nov186. Epub 2015 Sep 18.

PMID:
26385615
4.

Characteristics and treatments of large cystic brain metastasis: radiosurgery and stereotactic aspiration.

Kim M, Cheok S, Chung LK, Ung N, Thill K, Voth B, Kwon DH, Kim JH, Kim CJ, Tenn S, Lee P, Yang I.

Brain Tumor Res Treat. 2015 Apr;3(1):1-7. doi: 10.14791/btrt.2015.3.1.1. Epub 2015 Apr 29. Review.

6.

Single-Isocenter Frameless Volumetric Modulated Arc Radiosurgery for Multiple Intracranial Metastases.

Lau SK, Zakeri K, Zhao X, Carmona R, Knipprath E, Simpson DR, Nath SK, Kim GY, Sanghvi P, Hattangadi-Gluth JA, Chen CC, Murphy KT.

Neurosurgery. 2015 Aug;77(2):233-40; discussion 240. doi: 10.1227/NEU.0000000000000763.

7.

Frameless single-isocenter intensity modulated stereotactic radiosurgery for simultaneous treatment of multiple intracranial metastases.

Lau SK, Zhao X, Carmona R, Knipprath E, Simpson DR, Nath SK, Kim GY, Hattangadi JA, Chen CC, Murphy KT.

Transl Cancer Res. 2014 Aug 1;3(4):383-390.

8.

Brain metastasis and treatment.

Ahluwalia MS, Vogelbaum MV, Chao ST, Mehta MM.

F1000Prime Rep. 2014 Dec 1;6:114. doi: 10.12703/P6-114. eCollection 2014. Review.

9.

Treatment outcomes using CyberKnife for brain metastases from lung cancer.

Tamari K, Suzuki O, Hashimoto N, Kagawa N, Fujiwara M, Sumida I, Seo Y, Isohashi F, Yoshioka Y, Yoshimine T, Ogawa K.

J Radiat Res. 2015 Jan;56(1):151-8. doi: 10.1093/jrr/rru092. Epub 2014 Oct 25.

10.

Long-term outcome of gamma knife radiosurgery for metastatic brain tumors originating from lung cancer.

Bir SC, Ambekar S, Bollam P, Nanda A.

Surg Neurol Int. 2014 Sep 5;5(Suppl 8):S396-403. doi: 10.4103/2152-7806.140197. eCollection 2014.

11.

Stereotactic radiosurgery (SRS) for brain metastases: a systematic review.

Nieder C, Grosu AL, Gaspar LE.

Radiat Oncol. 2014 Jul 12;9:155. doi: 10.1186/1748-717X-9-155. Review.

12.
13.

Prognostic factors for survival and radiation necrosis after stereotactic radiosurgery alone or in combination with whole brain radiation therapy for 1-3 cerebral metastases.

Schüttrumpf LH, Niyazi M, Nachbichler SB, Manapov F, Jansen N, Siefert A, Belka C.

Radiat Oncol. 2014 May 2;9:105. doi: 10.1186/1748-717X-9-105.

14.

Phase I/II study of resection and intraoperative cesium-131 radioisotope brachytherapy in patients with newly diagnosed brain metastases.

Wernicke AG, Yondorf MZ, Peng L, Trichter S, Nedialkova L, Sabbas A, Kulidzhanov F, Parashar B, Nori D, Clifford Chao KS, Christos P, Kovanlikaya I, Pannullo S, Boockvar JA, Stieg PE, Schwartz TH.

J Neurosurg. 2014 Aug;121(2):338-48. doi: 10.3171/2014.3.JNS131140. Epub 2014 May 2.

15.

Current approaches to the treatment of metastatic brain tumours.

Owonikoko TK, Arbiser J, Zelnak A, Shu HK, Shim H, Robin AM, Kalkanis SN, Whitsett TG, Salhia B, Tran NL, Ryken T, Moore MK, Egan KM, Olson JJ.

Nat Rev Clin Oncol. 2014 Apr;11(4):203-22. doi: 10.1038/nrclinonc.2014.25. Epub 2014 Feb 25. Review.

16.

Imaging changes following stereotactic radiosurgery for metastatic intracranial tumors: differentiating pseudoprogression from tumor progression and its effect on clinical practice.

Ruzevick J, Kleinberg L, Rigamonti D.

Neurosurg Rev. 2014 Apr;37(2):193-201; discussion 201. doi: 10.1007/s10143-013-0504-8. Epub 2013 Nov 15. Review.

17.

A review of the clinical outcomes for patients diagnosed with brainstem metastasis and treated with stereotactic radiosurgery.

Lamm AF, Elaimy AL, Lamoreaux WT, Mackay AR, Fairbanks RK, Demakas JJ, Cooke BS, Lee CM.

ISRN Surg. 2013 Apr 11;2013:652895. doi: 10.1155/2013/652895. Print 2013.

18.

Erlotinib eradicates brain metastases from epidermal growth factor receptor mutant non-small cell lung cancer.

Jabbari S, Pins M, Kruczek K, Nabhan C.

Avicenna J Med. 2011 Oct;1(2):52-4. doi: 10.4103/2231-0770.90916.

19.

Fractionated radiosurgery for painful spinal metastases: DOSIS - a phase II trial.

Guckenberger M, Hawkins M, Flentje M, Sweeney RA.

BMC Cancer. 2012 Nov 19;12:530. doi: 10.1186/1471-2407-12-530.

20.

Physician self-reported treatment of brain metastases according to patients' clinical and demographic factors and physician practice setting.

Kress MA, Ramakrishna N, Makgoeng SB, Unger KR, Potosky AL.

Radiat Oncol. 2012 Nov 8;7:188. doi: 10.1186/1748-717X-7-188.

Items per page

Supplemental Content

Write to the Help Desk